Literature DB >> 18422921

Posaconazole as first line treatment for disseminated zygomycosis.

Trisha Peel, John Daffy, Karin Thursky, Peter Stanley, Kirsty Buising.   

Abstract

We describe the first case report of posaconazole use as first line agent in the treatment of disseminated zygomycosis with prosthetic hip joint and pulmonary involvement due to Rhizopus microsporus. This infection occurred in a heavily immunosuppressed patient with systemic lupus erythematosus.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18422921     DOI： 10.1111/j.1439-0507.2008.01499.x

Source DB:  PubMed          Journal:  Mycoses        ISSN： 0933-7407            Impact factor:   4.377


  10 in total

Review 1.  Human Pathogenic Entomophthorales.

Authors:  Raquel Vilela; Leonel Mendoza
Journal:  Clin Microbiol Rev       Date:  2018-08-29       Impact factor: 26.132

2.  Spondylodiscitis associated with skin lesions caused by Rhizopus in a patient with systemic lupus erythematosus.

Authors:  Larissa Silva de Saboya; Moara Alves Santa Bárbara Borges; Diego Gonçalves Camargo; Maria Auxiliadora de Paula Carneiro Cysneiros; Murilo Eugênio Oliveira; Adriana Oliveira Guilarde
Journal:  Infez Med       Date:  2022-03-01

3.  Mucor circinelloides as a cause of invasive maxillofacial zygomycosis: an emerging dimorphic pathogen with reduced susceptibility to posaconazole.

Authors:  Zia U Khan; Suhail Ahmad; Arnost Brazda; Rachel Chandy
Journal:  J Clin Microbiol       Date:  2009-01-26       Impact factor: 5.948

4.  Correlation of in vitro activity, serum levels, and in vivo efficacy of posaconazole against Rhizopus microsporus in a murine disseminated infection.

Authors:  M Mar Rodríguez; F Javier Pastor; Enrique Calvo; Valentina Salas; Deanna A Sutton; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2009-09-28       Impact factor: 5.191

Review 5.  Invasive fungal infection in haematopoietic stem cell transplant recipients: epidemiology from the transplant physician's viewpoint.

Authors:  E J Bow
Journal:  Mycopathologia       Date:  2009-04-03       Impact factor: 2.574

6.  Zygomycosis in Immunocompromised non-Haematological Patients.

Authors:  George Petrikkos; Miranda Drogari-Apiranthitou
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-03-15       Impact factor: 2.576

Review 7.  Mucormycosis in a renal transplant recipient: case report and comprehensive review of literature.

Authors:  Tamim Hamdi; Vanji Karthikeyan; George J Alangaden
Journal:  Int J Nephrol       Date:  2014-02-12

8.  Trichosporon asahii infection after total knee arthroplasty: A case report and review of the literature.

Authors:  Qiang Zuo; Lele Dong; Weidong Mu; Lingyun Zhou; Tongping Hu; Hua Zhang
Journal:  Can J Infect Dis Med Microbiol       Date:  2015 Jan-Feb       Impact factor: 2.471

Review 9.  Cutaneous mucormycosis.

Authors:  Ana Daniela Castrejón-Pérez; Esperanza C Welsh; Ivett Miranda; Jorge Ocampo-Candiani; Oliverio Welsh
Journal:  An Bras Dermatol       Date:  2017 May-Jun       Impact factor: 1.896

10.  Cutaneous mucormycosis in a chronic lymphocytic leukemia patient on ibrutinib.

Authors:  Katherine R Sittig; Leah G Laageide; Zaheer Akhtar; Geoffrey C Wall; Sudhir C Kumar
Journal:  IDCases       Date:  2021-04-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.